Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05792306 |
Other study ID # |
jia19920107 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
January 29, 2023 |
Est. completion date |
March 10, 2024 |
Study information
Verified date |
February 2023 |
Source |
Dove Medical Press Ltd |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The purpose of this study is to test whether the reduction of the sense of discomfort and
redness and swelling of the skin surrounding the wound of patients by use of the novel
electrolyzed water spray will relieve the inflammation of the skin.
Description:
In this study, water inculding tap water,pure water and salt water, and an apparatus for
producing electrolyzed water (https://www.deposon.com.cn; https://www.deposon.com)were used
to generate an electrolyzed water mist spray or spray. This instantly generated electrolyzed
water mist spray or spray has oxidation-reduction potential (ORP) ≥1200mv,and contains
non-specific total oxidation capacity which equals to 0.28±0.10ppm,0.06±0.04ppm and
3.92±0.39ppm of desolved ozone. This instantly generated electrolyzed water mist spray or
spray does not release detectable ≥0.1mg/m3 of gaseous ozone. This instantly generated
electrolyzed water mist spray or spray has pH 8.4±0.4 and releases negative air ion.The
apparatus for producing electrolyzed water has a positive electrode which is covered by a
conductive diamond material (Patent# CN215308550U). In this study, this novel electrolyzed
water device and the water spray are used to treat wounds created by skin laser surgery.